Difference between revisions of "CT Volumetry Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
 
(4 intermediate revisions by 2 users not shown)
Line 10: Line 10:
  
 
'''Recent Call Summaries:'''
 
'''Recent Call Summaries:'''
 +
*[[Media:05 26 2022 QIBA CT Volumetry BC Call-FINAL.pdf|05.26.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:04 20 2022 QIBA CT Volumetry BC Call-FINAL.pdf|04.20.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:03 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|03.15.2022 QIBA CT Volumetry BC Call Summary]]
 
*[[Media:02 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|02.15.2022 QIBA CT Volumetry BC Call Summary]]
 
*[[Media:02 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|02.15.2022 QIBA CT Volumetry BC Call Summary]]
  
Line 17: Line 20:
 
==Profile Development==
 
==Profile Development==
  
===Advanced Disease/Tumor Volume Change Profile===
+
'''Status - Balloting Streamlined Profile'''
 +
*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20220303.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2022.03.03
 +
*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20211209.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2021.12.09
  
'''Status - Working on Streamlining'''
+
The Technically Confirmed Profile is on the [[Profiles]] page.
*[[Media:QIBA_Profile_Streamlining_Proposal_-_CTVol_TumorVolumeChange-20220303.docx | CT Tumor Volume Change Profile - Streamlined]] Draft 2023.03.03
 
*[[Media:QIBA_Profile_Streamlining_Proposal_-_CTVol_TumorVolumeChange-20211209.docx | CT Tumor Volume Change Profile - Streamlined]] Draft 2021.12.09
 
  
The Technically Confirmed Profile is on the [[Profiles]] page.
+
'''Stage 4 Planning'''
 +
:* [https://docs.google.com/document/d/1Wcmkzp8N_2lLL-FCykNPwgsn1BJOs7Z9A1ZyTIkuGCo/edit?usp=sharing Draft Stage 4 Plan - Google Doc]
  
Past and Future
+
'''Past and Future'''
 
:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
 
:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
 
:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
 
:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
Line 45: Line 49:
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
+
*[[Media:Why QIBA CT specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
  
 
'''2011'''
 
'''2011'''
Line 55: Line 59:
 
'''2010'''
 
'''2010'''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
+
*[[Media:Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
  
 
==Reference Articles==
 
==Reference Articles==
Line 79: Line 83:
  
 
'''Round 3'''
 
'''Round 3'''
*[[Media:Second 3A Statistical and Image Processing Analysis.pdf | Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
+
*[[Media:Second 3A Statistical and Image Processing Analysis.pdf| Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
  
 
'''Round 4'''
 
'''Round 4'''
*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf | Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
+
*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf| Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
  
*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf | Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
+
*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf| Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
  
 
'''Round 5'''
 
'''Round 5'''
*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf | Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
+
*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf| Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
  
 
'''Round 6'''
 
'''Round 6'''
*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf | Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]
+
*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf| Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]

Latest revision as of 19:17, 17 May 2022

Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD
RSNA Staff Support: Julie Lisiecki

Meetings

  • Tcons are held periodically. Contact RSNA Staff for details.


Recent Call Summaries:


CT Volumetry BC Call Summaries Archive

Profile Development

Status - Balloting Streamlined Profile

The Technically Confirmed Profile is on the Profiles page.

Stage 4 Planning

Past and Future

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

  • VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
  • VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
  • VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
  • VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
  • VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
  • VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

Reference Materials

2012

2011

2010

Reference Articles

  • Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
  • Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
  • Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
  • Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

QIBA Funded Projects

Round 1

Round 2

Round 3

Round 4

Round 5

Round 6